Invention Grant
- Patent Title: Whole blood assay for measuring AMPK activation
-
Application No.: US14636041Application Date: 2015-03-02
-
Publication No.: US09383362B2Publication Date: 2016-07-05
- Inventor: Vadim Markovtsov , Yasumichi Hitoshi
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Bozicevic, Field & Francis LLP
- Agent James S. Keddie
- Main IPC: G01N33/573
- IPC: G01N33/573 ; G01N33/49 ; G01N33/53 ; G01N33/50

Abstract:
A method of sample analysis is provided. In certain embodiments, the method comprises: a) labeling cells of a blood sample using an antibody that specifically binds to phospho-AMPK or a phosphorylated target thereof, to produce a labeled sample; and b) measuring antibody binding by a population of blood cells of the labeled sample using flow cytometry. In particular embodiments, the method may further comprise, prior to the labeling step: contacting blood with a test agent ex vivo or in vivo; and comparing the evaluation to results obtained from a reference sample of blood cells.
Public/Granted literature
- US20150168408A1 Whole Blood Assay for Measuring AMPK Activation Public/Granted day:2015-06-18
Information query
IPC分类: